Elsen Pharma SA
Elsen Pharma reported total assets of €1.29m at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Aug 2026).
The score of Elsen Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -16 % Total assets +38 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Elsen Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Aug 2026
- Year ended 31 Dec 2024filed on 29 Sep 2025
- Year ended 31 Dec 2023filed on 09 Aug 2024
- Year ended 31 Dec 2022filed on 24 Jul 2023
- Year ended 31 Dec 2021filed on 04 Aug 2022
Elsen Pharma's financial analysis
- Solvency38.7%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Elsen Pharma
Elsen Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0446.359.356
- VAT number
- BE0446359356
- Peppol
- Registered · 0208:0446359356 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 15 Jan 1992
- Registered office
- 5530 Yvoir
- Latest accounts
- 2025 · filed on 25 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Elsen Pharma (SA) has been based in Yvoir since 1992, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 75,149 € and equity of 499,552 €; its revenue is not published. Its solvency stands at 38.7%, below the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Elsen Pharma
Companies in the same business, of comparable size and area, outside its group.
- Ascentim Rental and operating of own or leased real estate Asse · balance sheet €2.09m
- Phaverso Oostnieuwkerke Rental and operating of own or leased real estate Moorslede · balance sheet €1.08m
- Drankencentrale van Hyfte Rental and operating of own or leased real estate Wingene · balance sheet €1.23m
- Tassm Rental and operating of own or leased real estate Mettet · balance sheet €2.02m
- Darcimmo Rental and operating of own or leased real estate Alken · balance sheet €1.41m
- P&J Invest Rental and operating of own or leased real estate Bekkevoort · balance sheet €1.35m
- Huysegems Rental and operating of own or leased real estate Zaventem · balance sheet €1.33m
- Heyerick Property Rental and operating of own or leased real estate Nazareth-De Pinte · balance sheet €1.41m
Frequently asked questions about Elsen Pharma
What is the revenue of Elsen Pharma?
Elsen Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Elsen Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0446359356 for Elsen Pharma, if the company is VAT-registered. Its company number (CBE) is 0446.359.356.
Where is the registered office of Elsen Pharma?
According to the CBE register, the registered office of Elsen Pharma is in 5530 Yvoir.
What is the equity of Elsen Pharma?
At the close of the 2025 financial year, the equity of Elsen Pharma amounts to 499,552 €, a solvency of 38.7% of total assets.
Who manages Elsen Pharma?
The register lists 3 active mandates at Elsen Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Elsen Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →